ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 51 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,232 | +211.6% | 16,844 | +342.2% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 3,809 | -1.4% | 0.00% | – |
| Q2 2022 | $2,000 | -71.4% | 3,862 | -56.4% | 0.00% | – |
| Q1 2022 | $7,000 | -93.3% | 8,862 | -88.7% | 0.00% | – |
| Q4 2021 | $104,000 | +235.5% | 78,540 | +474.5% | 0.00% | – |
| Q3 2021 | $31,000 | -86.5% | 13,671 | -73.8% | 0.00% | – |
| Q2 2021 | $229,000 | -70.9% | 52,106 | -51.9% | 0.00% | – |
| Q1 2021 | $786,000 | +2811.1% | 108,325 | +1639.6% | 0.00% | – |
| Q4 2020 | $27,000 | +68.8% | 6,227 | +62.2% | 0.00% | – |
| Q3 2020 | $16,000 | -30.4% | 3,840 | +0.4% | 0.00% | – |
| Q2 2020 | $23,000 | -20.7% | 3,823 | +0.4% | 0.00% | – |
| Q1 2020 | $29,000 | -49.1% | 3,809 | -8.9% | 0.00% | – |
| Q4 2019 | $57,000 | +14.0% | 4,179 | -1.0% | 0.00% | – |
| Q3 2019 | $50,000 | -10.7% | 4,223 | +5.9% | 0.00% | – |
| Q2 2019 | $56,000 | +522.2% | 3,988 | +661.1% | 0.00% | – |
| Q1 2019 | $9,000 | -52.6% | 524 | -57.7% | 0.00% | – |
| Q4 2018 | $19,000 | – | 1,239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |